ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

QNME vs TMO // FREE CASH FLOW YIELD

Quanome Technologies Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: QNME 0 — TMO 10
▲ FREE CASH FLOW YIELD LEADER: TMO
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QNME VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC QNME TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 56.10% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -11.20% 9.30% -20.50 TMO /roic <GO>
EV/EBITDA & P/E Valuation — 30.4x — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -18.77% 2.40% -21.17 TMO /fcf-yield <GO>
Operating Margin -54.00% 17.40% -71.40 TMO /operating-margins <GO>
Net Profit Margin -60.00% 15.10% -75.10 TMO /net-margins <GO>
Revenue Growth (YoY) -65.00% 3.90% -68.90 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.24% -0.24 TMO /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.67 4.50 -3.83 TMO /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.8 62.9 -19.13 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.94 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 36.3x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $14.3M $262.22B -$262.20B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR QNME REV TMO REV QNME GROSS % TMO GROSS % QNME FCF TMO FCF
FY 2025 $2.8M $44.56B 56.1% — -$2.7M $6.29B
FY 2024 $18.3M $42.88B 20.3% — -$53.6K $7.27B
FY 2023 $12.9M $42.86B — — $39.3K $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QNME // BETA —
TMO // BETA 0.94